Long-term supplementation with a specific probiotic strain may improve gut health and lower inflammation in elderly women with low bone mineral density, says a new study. The data suggests this may lead to beneficial effects on bone metabolism.
Biogaia are in the news again with two studies that point to the Swedish firm’s Lactobacillus reuteri Protectis probiotic that appear to show promise for managing colic in breastfed infants.
A new study showing beneficial effects of L. reuteri lozenges against pregnancy gingivitis could open up new markets for probiotic producer BioGaia, says its manager director.
A study involving 167 breastfed and probiotic formula fed ‘excessive crying’ infants has found no benefits for the formula-fed ones, even though other studies showed probiotics could reduce the malady.
There is not enough evidence to support use of the probiotic Lactobacillus reuteri to manage colic or prevent crying infants, according to a new analysis.
Use of the probiotic Lactobacillus reuteri Protectis could help soothe babies suffering from a common condition known as colic, according to new research.
Supplementation with a probiotic could help to reduce the incidence of a cinnib gastrointestinal problem associated with premature babies, according to new research.
Swedish probiotics supplier and product manufacturer BioGaia has seen sales increase 16 per cent in 2010 to €27.77m from €23.08m in 2009, with after-tax profit increasing 31 per cent year-on-year to €5.35m.
Strong demand from Nestle for BioGaia’s Reuteri probiotic strains in the last six months has helped the Swedish probiotics specialist towards a strong H1.
Swedish probiotics specialist BioGaia this morning announced a deal with Nestlé Nutrition that will see its proprietary Lactobacillus reuteri strain employed in infant nutrition products globally.
Swedish probiotics developer BioGaia, made significant progress
towards profitability in the past year thanks to a take-off in
higher margin sales in Japan.
Leading Swedish food maker Procordia Food is to launch a series of
health-enhancing foods and has reached a deal with compatriot
BioGaia for use of its probiotic bacteria Lactobacillus
reuteri in products for the Nordic market.
